Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort

Neil H. Segal, Sai Hong I. Ou, Ani Balmanoukian, Matthew G. Fury, Erminia Massarelli, Julie R. Brahmer, Jared Weiss, Patrick Schöffski, Scott J. Antonia, Christophe Massard, Dan P. Zandberg, Samir N. Khleif, Feng Xiao, Marlon C. Rebelatto, Keith E. Steele, Paul B. Robbins, Natasha Angra, Xuyang Song, Shaad Abdullah, Marcus Butler

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort'. Together they form a unique fingerprint.

Medicine & Life Sciences